SEARCH

SEARCH BY CITATION

References

  • 1
    de Monchy J, Andersen PS, Bergmann KC, Chivato T, Holm-Hansen A, Jarisch R et al. Living and learning with allergy: a European perception study on respiratory allergic disorders. Respir Med 2004;98: 404412.
  • 2
    Bousquet J, Lockey R, Malling H. WHO Position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 1998;53(Suppl.):44.
  • 3
    Maasch HJ, Marsh DG. Standardized extracts: modified allergens – allergoids. Clin Rev Allergy 1987;5: 89106.
  • 4
    Akdis CA, Blaser K. Regulation of specific immune responses by chemical and structural modifications of allergens. Int Arch Allergy Immunol 2000;121: 261269.
  • 5
    Norman PS, Lichtenstein LM, Marsch DG. Studies of allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoids treatment of ragweed hay fever. J Allergy Clin Immunol 1981;68: 460470.
  • 6
    Norman PS, Lichtenstein LM, Kagey-Sobotka A, Marsch D. Controlled evaluation of allergoids in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol 1982;70: 248260.
  • 7
    Bousquet J, Hejjaoui A, Skassa-Brociek W, Guérin B, Maasch HJ, Dhivert H et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol 1987;80: 591598.
  • 8
    Bousquet J, Frank E, Soussana M, Hejjaoui A, Maasch HJ, Michel FB. Double-blind, placebo-controlled immunotherapy with a high-molecular-weight, formalinized allergoid in grass pollen allergy. Int Arch Allergy Appl Immun 1987;82: 550552.
  • 9
    Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol 1990;85: 490497.
  • 10
    Pastorello EA, Pravettoni V, Incorvaia C, Mambretti M, Franck E, Wahl R et al. Clinical and immunological effects of immunotherapy with alum-adsorbed grass allergoids in grass-pollen-induced hay fever. Allergy 1992;47: 281290.
  • 11
    Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year double-blind placebo-controlled study. Allergy 1997;52: 6574.
  • 12
    Malling HJ. Methodology and quality of immunotherapy trials. Allergy 2004;59: 482484.
  • 13
    Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991;21: 7783.
  • 14
    Bauer P, Koehne K. Evaluation of experiments with adaptive interim analysis. Biometrics 1994;50: 10291041.
  • 15
    Mosbech H, Osterballe O. Does the effect of immunotherapy last after termination of treatment? Follow-up study in patients with grass pollen rhinitis. Allergy 1988;43: 523529.
  • 16
    Malling HJ. Immunotherapy as an effective tool in allergy treatment. Allergy 1998;53: 461472.
  • 17
    Arvidsson MB, Lowhagen O, Rak S. Allergen specific immunotherapy attenuates early and late phase reactions in lower airways of birch pollen asthmatic patients; a double blind placebo-controlled study. Allergy 2004;59: 7480.
  • 18
    Juniper EF, Thompson AK, Ferrie PJ, Roberts JN. Development and validation of the mini rhinoconjunctivitis quality of life questionnaire. Clin Exp Allergy 2000;30: 132140.
  • 19
    Riechelmann H, Epple B, Gropper G. Comparison of conjunctival and nasal provocation test in allergic rhinitis to house dust mite. Int Arch Allergy Immunol 2003;130: 5159.
  • 20
    Frank E, Williams A, Cromwell O, Atkinson P, Rajakulasingam K. Effectiveness of a pre-seasonal allergoid immunotherapy in patients with seasonal allergic rhinitis due to grass pollen. J Allergy Clin Immunol 2001;107: S260.
  • 21
    Williams AM, Frank E, Meyer H, Cromwell O, Rajakulasingam RK. Effectiveness of pre-seasonal allergoid immunotherapy in patients with grass pollen allergy. Allergy 2002;57(Suppl. 73):5152.
  • 22
    Wachholz PA, Durham S. Induction of ‘blocking’ IgG antibodies during immunotherapy. Clin Exp Allergy 2003;33: 11711174.
  • 23
    Wachholz PA, Kristensen Soni N, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol 2003;112: 915922.
  • 24
    Anonymous. Position paper on allergen immunotherapy. Report of a BSACI working party. Clin Exp Allergy 1993;23(Suppl. 3):2731.
  • 25
    Thum-Oltmer S, Jäger L. Specific immunotherapy with allergoids: effective, safe, and long-lasting. Mod Aspects Immunobiol (in press).
  • 26
    Eng PA, Reinhold M, Gnehm HPE. Long-term efficacy of pre-seasonal grass pollen immunotherapy in children. Allergy 2002;57: 306312.